ArticleGland surgery2025
Bibliometric analysis of the top 100 most-cited articles on tissue expander use in breast reconstruction: insights from CiteSpace, VOSviewer, and Bibliometrix.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tissue expanders are widely used in both immediate and delayed breast reconstruction after mastectomy. With advances in surgical techniques and biomaterials, this field has seen continuous development. This study aimed to analyze the top 100 most-cited articles on tissue expanders in breast reconstruction to identify research trends and progress in this field. Methods: The top 100 most cited articles were selected from the Web of Science Core Collection (WoSCC) for a systematic search. Comprehensive bibliometric analyses were conducted using VOSviewer, CiteSpace, and Bibliometrix. Additionally, clinical trial data were retrieved from ClinicalTrials.gov (https://www.clinicaltrials.gov) and the World Health Organization International Clinical Trials Registry Platform (ICTRP) (https://trialsearch.who.int). Results: The top-cited articles span multiple disciplines, with the USA contributing the highest number of publications. China, Canada, and the UK ranked second in terms of publication volume. Representative institutions included the University of Michigan and Memorial Sloan Kettering Cancer Center. Key authors included Cordeiro PG and Wilkins EG. Frequent keywords were "implant", "mastectomy", "complications", and "radiotherapy". The most cited article was by Chun YS Conclusions: Research on tissue expanders in breast reconstruction focuses on surgical optimization, complication management, biomaterials, and patient-reported outcome measures (PROMs). Current trends emphasize personalized reconstruction strategies and improved postoperative care. Challenges remain in addressing patient variability and biomaterial safety. Further research is needed to refine individualized approaches and improve clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.